- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
8
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
8 companies
UCB
Market Cap: €25.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€136.30
7D
2.1%
1Y
12.5%
argenx
Market Cap: €32.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€524.20
7D
2.7%
1Y
55.4%
Hyloris Pharmaceuticals
Market Cap: €187.6m
Engages in the research, development, and manufacture of pharmaceutical products to address unmet medical needs.
HYL
€6.70
7D
16.5%
1Y
-44.2%
Oxurion
Market Cap: €463.9k
A biopharmaceutical company, develops medicines to prevent blindness.
OXUR
€0.10
7D
0.1%
1Y
-90.0%
European Medical Solutions
Market Cap: €22.8m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
ALEMS
€5.40
7D
-1.8%
1Y
-27.0%
BioSenic
Market Cap: €1.2m
A biotech company, focuses on developing clinical assets.
BIOS
€0.0018
7D
0%
1Y
-90.8%
Financière de Tubize
Market Cap: €4.9b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€110.20
7D
1.8%
1Y
19.9%
Celyad Oncology
Market Cap: €22.4m
A biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer.
CYAD
€0.54
7D
11.8%
1Y
59.1%